FDA Approves At-Home Starter Dose of Alzheimer's Drug
(MedPage Today) -- The FDA approved a new starting dosage regimen for the subcutaneous formulation of lecanemab (Leqembi Iqlik) to treat adults with Alzheimer's disease, the agency said Monday…
Read the full article2d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Cervical and Mammogram Screenings, Walterboro - Monday, December 14, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Bluffton - Tuesday, December 1, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Varnville - Wednesday, October 21, 2026
dph.sc.gov·just now
Cervical and Mammogram Screenings, Goose Creek - Tuesday, September 8, 2026
dph.sc.gov·just now
US FDA approves novel cholesterol pill for high-risk patients
Global News·just now
Comments
Sign in to join the conversation.
No comments yet. Be the first.